KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Revenue (2016 - 2025)

Historic Revenue for Inovio Pharmaceuticals (INO) over the last 17 years, with Q1 2025 value amounting to $65343.0.

  • Inovio Pharmaceuticals' Revenue changed N/A to $65343.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $182337.0, marking a year-over-year decrease of 1036.12%. This contributed to the annual value of $217756.0 for FY2024, which is 7382.77% down from last year.
  • Per Inovio Pharmaceuticals' latest filing, its Revenue stood at $65343.0 for Q1 2025.
  • In the past 5 years, Inovio Pharmaceuticals' Revenue ranged from a high of $9.2 million in Q3 2022 and a low of $65343.0 during Q1 2025
  • Moreover, its 5-year median value for Revenue was $225971.0 (2023), whereas its average is $876809.0.
  • As far as peak fluctuations go, Inovio Pharmaceuticals' Revenue soared by 303822.28% in 2022, and later tumbled by 9575.66% in 2023.
  • Over the past 5 years, Inovio Pharmaceuticals' Revenue (Quarter) stood at $839115.0 in 2021, then crashed by 85.14% to $124666.0 in 2022, then dropped by 17.66% to $102651.0 in 2023, then increased by 13.97% to $116994.0 in 2024, then crashed by 44.15% to $65343.0 in 2025.
  • Its Revenue was $65343.0 in Q1 2025, compared to $116994.0 in Q4 2024 and $100762.0 in Q2 2024.